NCT00188825View on ClinicalTrials.gov

Study Comparing Simulect Plus Standard Immunosuppression to Standard Immunosuppression Alone for the Prevention of Acute Rejection and Bronchiolitis Obliterans in Lung Transplant

PHASE3CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
COPDEmphysemaAlpha-1 Antitrypsan Deficiency
Interventions
OTHER

placebo

DRUG

basiliximab

Trial Locations (1)

M5G 2C4

Toronto General Hospital, Toronto

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

University Health Network, Toronto

OTHER